NCT00887913已完成不适用
Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 69
- 试验地点
- 6
- 主要终点
- Improvement in Fine Lines
研究概览
简要总结
The purpose of this study is to determine whether the Matrix RF applicator is effective in the treatment of facial skin texture and wrinkle reduction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Informed consent agreement signed by the subject.
- •Healthy males or females older than 21 years of age.
- •Having at least two facial sub-areas with visible lines/wrinkles and elastosis, which correlate to a score of 2 6 on the Fitzpatrick Classification of Wrinkling and Degree of Elastosis.
- •Fitzpatrick skin type I-VI (note: skin type VI should not undergo treatment using resurfacing procedure parameters).
- •Willingness to follow the treatment and follow-ups schedule and the post-treatment care.
- •For female candidates - post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study (i.e., oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide, or abstinence).
排除标准
- •Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breastfeeding.
- •Having any active electrical implant anywhere in the body, such as a pacemaker or an internal defibrillator.
- •Having a permanent implant in the treated area, such as metal plates and screws, or an injected chemical substance.
- •Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
- •Having received acne treatment with a light-based device within 1 month of treatment or during the study.
- •Use of isotretinoin (Accutane®) within 6 months of treatment or during the study.
- •Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) one week before and after each treatment session.
- •Use of retinoids, antioxidants or skin nourishing supplements within 2 months of treatment or during the study.
- •Having received a facial dermabrasion or chemical peel treatment within 3 months of treatment or during the study.
- •Having received treatment with light, RF or other devices in the treated area within 6 months of treatment or during the study.
- •Having received Botox/collagen/fat injections or other methods of augmentation with injected or implanted material in the treated area within 9 months of treatment or during the study.
- •Having undergone a resurfacing procedure, face lift or eyelid surgery within a year of treatment or during the study.
- •Having undergone any other surgery in the treated area within 6 months of treatment (or more if skin has not healed completely) or during the study.
- •History of keloid scarring or of abnormal wound healing.
- •Suffering from current or history of significant skin conditions in the treated area or inflammatory skin conditions, including, but not limited to: excessive skin dryness, psoriasis, eczema, rash, rosacea (particularly severe open wound stage), indurate acne, varicella scars, open lacerations or abrasions and active cold sores or herpes sores prior to treatment (duration of resolution as per the Investigator's discretion) or during the treatment course.
- •History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications.
- •History of epidermal or dermal disorders (particularly if involving collagen or microvascularity).
- •History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation.
- •Suffering from hormonal imbalance, as per the Investigator's discretion.
- •Having a known anticoagulative or thromboembolic condition or taking anticoagulation medications one week prior to and during the treatment course (to allow inclusion, temporary cessation of use as per the subject's physician discretion).
- •Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the areas to be treated, including presence of malignant or pre-malignant pigmented lesions.
- •Suffering from significant concurrent illness, such as cardiac disorders, diabetes (type I or II), or pertinent neurological disorders.
- •Vascular lesion, tattoo or permanent make-up in the treated area.
- •Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study.
- •Participation in a study of another device or drug within one month prior to enrollment or during the study.
- •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
结局指标
主要结局
Improvement in Fine Lines
时间窗: 4 week follow up after last treatment
Improvement of fine lines (wrinkles) assessed per anatomical area treated based on Improvement Scale: 0-4 where higher scores indicate a better outcome. Improvement is graded by means of photographs taken at baseline vs treatment 3 and baseline vs 6week follow up
Improvement in Smoothness
时间窗: 4 weeks follow up post last treatment
Smoothness of anatomical treated area assessed based on Improvement Scale 0-4.Where higher scores indicate a better outcome. Improvement is graded by means of photographs taken at baseline vs treatment 3 and baseline vs 6week follow up
Improvement in Brightness
时间窗: 4 week follow up post last treatment
Assess the improvement in brightness of the treated anatomical area using Improvement Scale where higher scores indicate a better outcome. Improvement is graded by means of photographs taken at baseline vs treatment 3 and baseline vs 6week follow up
次要结局
未报告次要终点
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and WrinklesAcne Scars - Mixed Atrophic and HypertrophicWrinkleNCT04057768Venus Concept10
已完成
不适用
A Study on the Effectiveness and Safety Evaluation of Combination Therapy With 1,927nm Thulium Laser and Fractional Microneedle Radiofrequency Equipment for Improvement of Skin AgingWrinkleNCT03739398Yonsei University26
进行中（未招募）
不适用
Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)NCT06682377Seoul National University Hospital159
已完成
不适用
Clinical Study To Evaluate Paired Treatment With An Alexandrite Laser And Radiofrequency Microneedling For Facial AgingWrinkleDyschromiaPhotoagingNCT05388604Cynosure, Inc.42
Unknown
不适用
Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.Vaginal LaxityUrinary IncontinenceSexual DysfunctionNCT03280446SHERRY Thomas30